Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2026-03-06 @ 9:43 AM
Study NCT ID:
NCT02128958
Status:
COMPLETED
Last Update Posted:
2022-10-04
First Post:
2014-04-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Sponsor:
Can-Fite BioPharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-27
First Submit QC Date:
None
Study First Post Date:
2014-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-04
Results First Submit QC Date:
None
Results First Post Date:
2021-12-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-26
Last Update Post Date:
2022-10-04
Last Update Post Date Type:
ACTUAL